You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Donor Leukocyte Engraftment

Showing 1 - 25 of 4,282
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Tolerance Trial in Palo Alto (Combined Deceased Donor Kidney and Hematopoietic Cell Transplants)

Enrolling by invitation
  • Immune Tolerance
  • Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
  • Palo Alto, California
    Stanford University
May 6, 2022

Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia

Recruiting
  • Acute Leukemia
  • No intervention, observation study
  • Hangzhou, Zhejiang, China
    Clinical research ethics committee of the first affiliated hospi
Oct 6, 2023

Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

No longer available
  • Chronic Myeloid Leukemia
  • +2 more
  • G-CSF mobilized CD34+ selected cells for transplantation
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)

Recruiting
  • Living Donor Kidney Transplantation
  • Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
  • Palo Alto, California
  • +1 more
May 6, 2022

Nanoparticle for DSA Removal

Recruiting
  • Kidney Failure
  • Presence of Donor Specific Antibodies
    • Zurich, ZH, Switzerland
      University Hospital Zurich, Division of Anaesthesiology
    Mar 11, 2022

    Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Total-Body Irradiation
    • +5 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Sep 7, 2022

    Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

    Not yet recruiting
    • Kidney Transplant Rejection
    • MDR-102
    • Immunosuppressive Agents
    • (no location specified)
    Apr 4, 2022

    Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

    Completed
    • Minimal Residual Disease
    • +3 more
    • Daratumumab
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Mar 2, 2022

    Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

    Active, not recruiting
    • Hematologic Malignancy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 21, 2022

    Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

    Completed
    Has Results
    • Hemophagocytic Lymphohistiocytosis
    • +5 more
    • Hematopoietic Stem Cell Transplant
    • Birmingham, Alabama
    • +21 more
    Dec 6, 2022

    Fanconi Anemia Trial in Stanford (drug, device, biological)

    Recruiting
    • Fanconi Anemia
    • Stanford, California
      Stanford University
    Feb 2, 2022

    Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

    Recruiting
    • Sickle Cell Anemia
    • Beta Thalassemia
    • TBI
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

    Recruiting
    • Primary Immune Deficiency Disorder
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University
    Oct 20, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell

    No longer available
    • Acute Lymphoblastic Leukemia
    • +11 more
    • CD34+ enriched, T Cell Depleted donor stem cell product
    • San Francisco, California
      University of California, San Francisco
    May 25, 2021

    Immunoglobulins, Plasmapheresis and Rituximab in Lung

    Recruiting
    • Lung Transplantation
    • Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
    • blood samples
    • Hannover, Germany
      Hannover Medical School, Department of Cardiothoracic, Transplan
    Aug 30, 2021

    Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

    Recruiting
    • Sickle Cell Disease
    • Bone Marrow Transplant (BMT)
    • +7 more
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    Sep 13, 2022

    Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

    Recruiting
    • Leukemia, Myeloid, Acute
    • La Jolla, California
    • +8 more
    Jan 31, 2023

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

    Recruiting
    • Hematopoietic Malignancy
    • +2 more
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Nov 6, 2023

    Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

    Recruiting
    • Sickle Cell Disease
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Enrolling by invitation
    • Severe Combined Immune Deficiency (SCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

    Completed
    Has Results
    • Leukemia
    • Lymphoma
    • Total Lymphoid Irradiation
    • +10 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 28, 2022

    GVHD Trial in United States (Abatacept)

    Recruiting
    • Graft Versus Host Disease
    • Birmingham, Alabama
    • +8 more
    Mar 16, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (ATIR101, Haploidentical

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +2 more
    • ATIR101
    • +3 more
    • Brugge, Belgium
    • +10 more
    May 17, 2021

    Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Cyclophosphamide, Tacrolimus,

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Maywood, Illinois
      Loyola University Medical Center
    Apr 22, 2021

    Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

    Suspended
    • Hematologic Neoplasms
    • donor lymphocyte infusion
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 30, 2022